FDA Approves Arcutis’ ZORYVE® (roflumilast) Topical Foam, 0.3% for the Treatment of Seborrheic Dermatitis in Individuals Aged 9 Years and Older
Ultimovacs Announces Completion of Exploratory Phase I TENDU Study of TET Vaccine Technology Platform Meeting the Primary Endpoint
MDxHealth Announces Completion of Transition to Single Listing on Nasdaq
Read the rest here:
MDxHealth Announces Completion of Transition to Single Listing on Nasdaq
Mithra Receives Positive DSMB Opinion on DONESTA® European Phase 3 Trial
Nicox Announces First Patient Screened in the Whistler Phase 3b Trial of NCX 470 in Glaucoma
Annovis Bio Appoints Andrew Walsh as Vice President Finance
Ovid Therapeutics to Present Five Abstracts Supporting its Epilepsy Programs at the 77th American Epilepsy Society Annual Meeting (2023)
Akari Therapeutics Appoints Experienced Life Sciences Entrepreneur Samir R. Patel, M.D. to Board of Directors
Spectral Medical Announces CFO Departure
Originally posted here:
Spectral Medical Announces CFO Departure
Weight Loss Treatment: SciSparc’s Obesity Drug Showed Positive Results in a Pre-Clinical Trial
Weight loss MEAI: Clearmind Medicine’s Novel Obesity Drug Showed Positive Results in a Pre-Clinical Trial
Allogene Therapeutics Announces Participation in December Investor Conference
Read the original post:
Allogene Therapeutics Announces Participation in December Investor Conference
Scilex Holding Company Generates Monthly Revenue In November 2023 And Provides Certain Preliminary Unaudited Financial Results For Gross And Net Sales…
Avenue Therapeutics to Present at American Epilepsy Society 2023 Annual Meeting
Read the original here:
Avenue Therapeutics to Present at American Epilepsy Society 2023 Annual Meeting
Number of voting rights as of November 30, 2023
Neurona Therapeutics Presents New Clinical Data from First Cohort in Ongoing Phase I/II Open-Label Trial of NRTX-1001 Cell Therapy for Drug-resistant…
RetinalGeniX Technologies Inc. Announces Hiring of Interim CFO
Continued here:
RetinalGeniX Technologies Inc. Announces Hiring of Interim CFO
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Read this article:
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)